Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
First-of-its-Kind Surgery Performed on Western Lowland Gorilla at the San Diego Zoo Safari Park
-
Premier American Uranium Successfully Completes Drilling Program at Cebolleta Project, New Mexico and Delivers Samples for Advanced Metallurgical Testing
-
CSL Group Acquires IoTM Solutions to Power Global eSIM Orchestration
-
Olive Garden Announces the Return of its Iconic Never-Ending Pasta Pass
-
Kamada Highlights CYTOGAM® Study Results Presented at the 2026 ISHLT Annual Meeting
-
Tonix Pharmaceuticals Announces Major Managed Medicare Payer Agreement for TONMYA®
-
KASTLE ASSEMBLES INDUSTRY DEFINING LEADERSHIP TEAM TO RESHAPE THE MANAGED PHYSICAL SECURITY MARKET
-
Zooby Urges San Antonio Homeowners to Inspect Roofs Before Filing After Report Finds 51% of USAA Homeowners' Claims Closed Without Payment
-
Talisker Expands Bralorne Gold Project to 24,000 hectares, 40km along strike
-
InMode to Report Second Quarter 2026 Financial Results on August 5, 2026, Expects Q2 Revenue Between $95.2M-$95.4M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M
-
Rural King Continues Ohio Growth with new Lancaster Location
-
Defense Metals Provides Corporate Update Highlighting Continued Execution and Strategic Momentum
-
NetraMark Engages AM Public Relations to Support Strategic Communications and Market Awareness
-
Pulsenmore Selected for Israel Innovation Authority and Ministry of Health Program to Lead an $1 Million AI Development Project
-
"We Must Act Now": Sixteen Nobel Laureates Join Leading Economists and AI Researchers in Call to Prepare for AI's Economic Transformation
-
CoreCivic to Redeem 4.750% Senior Notes Due 2027
-
Renewables Remain the Lowest-Cost New-Build Generation Despite Rising Cost Pressures, Lazard's 2026 Levelized Cost of Energy+ Report Finds
-
EXEED Showcases VX and RX at Riyadh’s Largest Fan Zone, Where Premium Technology Meets Football Passion
-
Chai Discovery Announces Collaboration with Novartis to Advance AI-Driven Antibody Discovery
-
Perk Becomes First to Connect Travel, Spend, Invoicing and Events Through a Single MCP
-
Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults With Narcolepsy Type 1 and Type 2 in Long-Term Extension Study Interim Analysis
-
Ionis doses first participant in Phase 1-2 ASCEND study of ION337 in Dravet syndrome
-
Armata Pharmaceuticals Receives Agreement from FDA on Initial Pediatric Study Plan for AP-SA02 for the Treatment of Complicated Staphylococcus aureus Bacteremia
-
Capital Square Fully Subscribes Richmond Active-Adult DST Offering
-
CareXM and OnePoint Patient Care Partner to Get Medications to Hospice Patients Faster After Hours
-
Fastmail Launches EU-Hosted Email Infrastructure, Giving Customers Control Over Where Their Data Lives
-
Alliance Resource Partners, L.P. Announces Second Quarter 2026 Earnings Conference Call
-
VitalHub Announces Acquisition of Buddy Healthcare
-
WRAP Opens Q3 with $1.2 Million in International Orders, Reaffirms 100% Revenue Growth Target for 2026 Following Landmark Federal Declassification Ruling
-
Adlai Nortye Expands Scientific Advisory Board with Appointment of Two Leading Medical Oncologists
-
First Hawaiian, Inc. to Acquire TriCo Bancshares and Provide Preliminary 2026 Second Quarter Results
-
Plug Power Announces Sale of Graham, Texas Project and Staged Closing of New York Gateway Project with Stream Data Centers, Expects $80 Million in Near-Term Liquidity as Part of $275 Million-Plus Init
-
Brain Training Shown to Reduce Amyloid Indicative of Alzheimer’s
-
Tailored Brands, Inc. Publicly Files Registration Statement for Initial Public Offering of Common Stock
-
Factorial and Tulip Seal Strategic Partnership after Successful Flight Test
-
Measurabl Expands Partner Network with Six Leading Service Providers as New Members
-
VERAXA Biotech to Launch AI-enabled Drug Discovery Collaboration with Ardigen to Support Growing BiTAC® Pipeline
-
Q32 Bio Announces Positive 36-Week Topline Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata
-
Fury Reports Intercept of 7.0 g/t Gold over 21.0 Metres at Eau Claire and Mobilizes Third Drill Rig
-
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
-
Factory-Customized, Performance Enhanced: G700 Top Fire to Debut in the Middle East
-
AECOM selected to help advance major rail transportation project in Australia, The Wave – Stage 1
-
The GEO Group Announces Contract for Company-Leased 1,188-Bed Big Horn Facility in Colorado
-
YieldMax® ETFs Announces Distributions on MSST, NVIT, and TEST
-
Man Group PLC : Form 8.3 - DCC Plc
-
N-able Appoints Cybersecurity Sales Veteran Russell Rosa as Chief Revenue Officer to Drive Upmarket Expansion and Accelerate Partner-Led Growth Across the Channel
-
Glory Family Heritage (Gloryfh Limited ) Wins 7 Awards at Bloomberg Businessweek Chinese Edition “Financial Institutions 2026”
-
Resideo To Present Strategy and Financial Framework as Pure-Play Building Technologies Company at Investor Day
-
All Three Independent Proxy Advisory Firms Recommend Genesco Shareholders Vote “FOR” All Nine of Genesco’s Directors
-
ANI Pharmaceuticals Announces Positive Six-Month Topline Data from the Phase 4 Open-Label, Single-Arm SYNCHRONICITY Trial Evaluating Fluocinolone Acetonide Intravitreal Implant in Patients with Chroni
